Drugs / amoxicillin/clavulanate
last change Dec 2022 re-read 2 minutes ago

amoxicillin/clavulanate

Developed for
multidrug-resistant tuberculosis
Investigated by
Centre for the AIDS Programme of Research in South Africa

Trials 1 · a red edge is where a trial was stopped

201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03237182 Jun 2017 → Dec 2022 multidrug-resistant tuberculosis Centre for the AIDS Programme of Research in South Africa Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as amoxicillin/clavulanate “meropenem, amoxicillin/clavulanate, clarithromycin” NCT03237182